Skip to main content

Table 2 Key design feature comparison between countries

From: Pragmatic cluster-randomized trial of home-based preventive treatment for TB in Ethiopia and South Africa (CHIP-TB)

 

Ethiopia

South Africa

Study population – index patients

Clinically diagnosed and bacteriologically confirmed pulmonary TB patients

Bacteriologically confirmed pulmonary TB patients

Study population – child contacts

Children < 15 years of age

Children < 5 years of Age

TPT regimena

3HP for those 3 2 years

3RH for those < 2 years

6H for those on ART

3RH for those 0-5 years

6H for those on ART

Community-based care model

Health extension worker based at health post in the community

Outreach team leader (professional nurse) teamed with community health worker

TPT initiation and follow-up

Performed by health extension worker;

Task-shared with clinic TB focal person

Performed by professional nurse;

Task-shifted from clinic TB focal nurse to a community-based health nurse

Persons responsible for TPT initiation and follow-up during trial

Utilized health system’s TB focal persons and health extension workers

Research nurse and clinic’s TB focal person

HIV testing

Not performed at household visits

Performed at household visits

  1. a3HP is 12 weekly doses of rifapentine and isoniazid; 3RH is 3 months of daily rifampicin and isoniazid; 6H is 6 months of daily isoniazid